Skip to content

Insider · CIK 0001766853

Acorn Bioventures, L.p.

owner

Files at OKUR (OnKure Therapeutics, Inc.). First filing May 19, 2025, latest May 19, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$2.6M bought, $0 sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

OKUR: OnKure Therapeutics, Inc.

OKUROct 9, 2026 · close 2.41

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
50Moderate
OKURbuy
OnKure Therapeutics, Inc.
$2.6M
1,400,000 shares
+97%+13% from low-89% from high

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
May 15, 2025OKUR
OnKure Therapeutics, Inc.
POpen-market purchase
Common Stock
+270,270$1.85$500k1,709,944May 19, 2025
May 15, 2025OKUR
OnKure Therapeutics, Inc.
POpen-market purchase
Common Stockindirect: By Acorn Bioventures 2, L.P.
+1,129,730$1.85$2.1M1,129,730May 19, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Acorn Bioventures, L.p.: insider trades and track record | InsiderTell